Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phillip J Bergen

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
The Medical Journal of Australia|February 4, 2014
The after-life of drugs: a responsible care initiative for reducing their environmental impactPhillip J Bergen, Simon E Appel
Current Opinion in Pharmacology|August 13, 2011
Dosing of colistin-back to basic PK/PDPhillip J Bergen, Jian Li, Roger L Nation
International Journal of Molecular Sciences|November 13, 2021
Antimicrobial Peptides: An Update on Classifications and DatabasesAhmer Bin Hafeez, Xukai Jiang, Phillip J Bergen, et al.
Antimicrobial Agents and Chemotherapy|November 22, 2021
Differences in Fosfomycin Resistance Mechanisms between Pseudomonas aeruginosa and <i>Enterobacterales</i>Dina Zheng, Phillip J Bergen, Cornelia B Landersdorfer, et al.
Antimicrobial Agents and Chemotherapy|May 26, 2006
Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosaPhillip J Bergen, Jian Li, Craig R Rayner, et al.
British Journal of Clinical Pharmacology|January 15, 2021
Evaluation of intravenous to oral antimicrobial switch at a hospital with a tightly regulated antimicrobial stewardship programSharmila Khumra, Andrew A Mahony, Phillip J Bergen, et al.
Frontiers in Pharmacology|May 2, 2018
Synergistic Killing of Polymyxin B in Combination With the Antineoplastic Drug Mitotane Against Polymyxin-Susceptible and -Resistant <i>Acinetobacter baumannii</i>: A Metabolomic StudyThien B Tran, Phillip J Bergen, Darren J Creek, et al.
Exploratory Research in Clinical and Social Pharmacy|April 28, 2022
Coaching ward pharmacists in antimicrobial stewardship: A pilot studySharmila Khumra, Andrew A Mahony, Kay Stewart, et al.
Current Opinion in Microbiology|July 23, 2013
PK/PD models in antibacterial developmentTony Velkov, Phillip J Bergen, Jaime Lora-Tamayo, et al.
Frontiers in Microbiology|May 1, 2018
Novel Polymyxin Combination With Antineoplastic Mitotane Improved the Bacterial Killing Against Polymyxin-Resistant Multidrug-Resistant Gram-Negative PathogensThien B Tran, Jiping Wang, Yohei Doi, et al.
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
The Medical Journal of Australia|February 4, 2014
The after-life of drugs: a responsible care initiative for reducing their environmental impactPhillip J Bergen, Simon E Appel
Current Opinion in Pharmacology|August 13, 2011
Dosing of colistin-back to basic PK/PDPhillip J Bergen, Jian Li, Roger L Nation
International Journal of Molecular Sciences|November 13, 2021
Antimicrobial Peptides: An Update on Classifications and DatabasesAhmer Bin Hafeez, Xukai Jiang, Phillip J Bergen, et al.
Antimicrobial Agents and Chemotherapy|November 22, 2021
Differences in Fosfomycin Resistance Mechanisms between Pseudomonas aeruginosa and <i>Enterobacterales</i>Dina Zheng, Phillip J Bergen, Cornelia B Landersdorfer, et al.
Antimicrobial Agents and Chemotherapy|May 26, 2006
Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosaPhillip J Bergen, Jian Li, Craig R Rayner, et al.
British Journal of Clinical Pharmacology|January 15, 2021
Evaluation of intravenous to oral antimicrobial switch at a hospital with a tightly regulated antimicrobial stewardship programSharmila Khumra, Andrew A Mahony, Phillip J Bergen, et al.
Frontiers in Pharmacology|May 2, 2018
Synergistic Killing of Polymyxin B in Combination With the Antineoplastic Drug Mitotane Against Polymyxin-Susceptible and -Resistant <i>Acinetobacter baumannii</i>: A Metabolomic StudyThien B Tran, Phillip J Bergen, Darren J Creek, et al.
Exploratory Research in Clinical and Social Pharmacy|April 28, 2022
Coaching ward pharmacists in antimicrobial stewardship: A pilot studySharmila Khumra, Andrew A Mahony, Kay Stewart, et al.
Current Opinion in Microbiology|July 23, 2013
PK/PD models in antibacterial developmentTony Velkov, Phillip J Bergen, Jaime Lora-Tamayo, et al.
Frontiers in Microbiology|May 1, 2018
Novel Polymyxin Combination With Antineoplastic Mitotane Improved the Bacterial Killing Against Polymyxin-Resistant Multidrug-Resistant Gram-Negative PathogensThien B Tran, Jiping Wang, Yohei Doi, et al.
Pageof 9